Andrew J Davies

20PUBLICATIONS
241CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 18, 2026
A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

|Aug 23, 2026
The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.

|Mar 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.

Andrea Kuhnl, Amy A Kirkwood, Michael Northend

|Dec 02, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly

|Sep 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.

Emanuele Zucca, Luca Ceriani, Giovannino Ciccone

|Sep 08, 2025
CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Lara E Buermann, Louise Stanton, Matthew J J Rose-Zerilli

Pageof 4

Frequent Collaborators

6 joint publications

Peter W M Johnson

5 joint publications

Pamela McKay

5 joint publications

David W Scott

4 joint publications

Emanuele Zucca